Enlivex Therapeutics
ENLV
ENLV
17 hedge funds and large institutions have $2.96M invested in Enlivex Therapeutics in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
4
Closed
4
Calls
$54K
Puts
$22K
Net Calls
+$32K
Net Calls Change
+$76K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$2.41M |
| 2 |
2
Morgan Stanley
New York
|
$348K |
| 3 |
XT
3
XTX Topco
George Town,
Cayman Islands
|
$35.2K |
| 4 |
4
Goldman Sachs
New York
|
$16.2K |
| 5 |
5
Renaissance Technologies
New York
|
$102K |
